Iron chelators target both proliferating and quiescent cancer cells.
about
MYC is downregulated by a mitochondrial checkpoint mechanism.Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor.EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to Improve Prediction Accuracy.Growth Inhibition of a Novel Iron Chelator, DpdtC, against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy-Mediated Lysosomal ROS Generation
P2860
Iron chelators target both proliferating and quiescent cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Iron chelators target both proliferating and quiescent cancer cells.
@en
Iron chelators target both proliferating and quiescent cancer cells.
@nl
type
label
Iron chelators target both proliferating and quiescent cancer cells.
@en
Iron chelators target both proliferating and quiescent cancer cells.
@nl
prefLabel
Iron chelators target both proliferating and quiescent cancer cells.
@en
Iron chelators target both proliferating and quiescent cancer cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Iron chelators target both proliferating and quiescent cancer cells
@en
P2093
Joachim Gullbo
Leoni Kunz Schughart
Maria Hägg Olofsson
Mårten Fryknäs
Peter Nygren
Rolf Larsson
Stig Linder
Ulf Bremberg
Xiaonan Zhang
P2860
P2888
P356
10.1038/SREP38343
P407
P577
2016-12-07T00:00:00Z